The calmodulin and calcium dependence of human adenylate cyclase from the second part of the duodenum was assessed in washed particulate preparations of biopsy specimens by investigating (a) the concentration dependent effects of free [Ca2+I on enzyme activity, (b) the effects of exogenous calmodulin on enzyme activity in ethylene glycol bis (b-aminoethyl ether) 
Adenylate cyclase is a basolateral membrane enzyme which catalyses the formation of adenosine 3'-5' monophosphate (cyclic AMP) from adenosine triphosphate (ATP). In the intestinal epithelium adenylate cyclase and cyclic AMP are involved in the regulation of water and electrolyte transport, particularly Cl-secretion and Na+ absorption. Changes in intracellular free calcium have also been shown to be important in the regulation of intestinal electrolyte transport.' Activation of adenylate cyclase is thought to be important in a number of gut disorders such as the secretory diarrhoea associated with cholera and vasoactive intestinal peptide secreting tumours. 23 Calmodulin is an ubiquitous intracellular calcium binding protein which influences many 
Methods

COLLECTION OF BIOPSY SPECIMENS
Patients presenting at the clinic with diarrhoea or iron deficiency anaemia were biopsied as part of diagnostic investigations to exclude malabsorption. Biopsy specimens of the second part of the duodenum were collected as previously described. 1 ' Two specimens were placed in formalin for histological examination to exclude villous abnormalities. Those for adenylate cyclase studies were immediately placed in liquid nitrogen. Only specimens from patients subsequently found to have normal histology, who had no underlying upper gastrointestinal disease, and who were not taking any medication were used for these studies. Ethical permission for the study was obtained from the Nottingham City Hospital Ethical Committee and patients gave informed written consent.
TISSUE PREPARATIONS
The presence of extracellular and intracellular fluids in tissue homogenates has been shown to interfere with adenylate cyclase activity.'"'6 We therefore washed biopsy homogenates with a series of homogenisation and centrifugation steps. Four or five biopsy specimens from one patient were homogenised in 2 ml ice cold 2 mmol/l HEPES buffer, pH 7T5, containing 5 mmol/l MgCl2 and 5 mmol/l EGTA (MEH) using 10 strokes of a Potter S homogeniser (B Braun) at 1200 rpm. The homogenate was made up to 12 ml and was centrifuged at 2500 g for 20 minutes at 4°C. The pellet was resuspended in 2 ml fresh MEH and the homogenisation/centrifugation procedure repeated twice more.
Any large tissue fragments remaining after the second homogenisation were removed. Microscopic examination showed them to be underlying muscularis mucosa and not epithelium. 17 The third pellet was resuspended in 2.4 ml MEH and homogenised a fourth time using an UltraTurrax (Janke & Kunkel, Ika-Werk) at maximum speed setting for 15 seconds. Calmodulin may be removed from membrane preparations by washing them in EGTA buffers.5 Therefore, in experiments in which no attempt was made to remove endogenous calmodulin EGTA was omitted from the tissue buffer. All An alternative way ofassessing the importance of Ca2+ in our assay system was to measure the concentration dependent effects of the Ca2+ chelating agent EGTA on adenylate cyclase activity (Fig 2) . NaF stimulated adenylate cyclase activity was inhibited by EGTA in a concentration dependent manner with 50% inhibition at 2.5 mmol/l. Attempts to restore EGTA inhibited adenylate cyclase activity with Ca2+ did not result in a recovery of the enzyme's activity, indicating direct inhibition of adenylate cyclase activity by EGTA. A slight but highly significant increase in basal adenylate cyclase 60- (Table  II) . None of the assay conditions shown resulted in a stimulation of adenylate cyclase activity over controls in the presence or absence of 10 mmol/l NaF.
The possibility existed that our assay methods were incapable of detecting calmodulin dependent adenylate cyclase activity. We therefore measured adenylate cyclase activity in a tissue well recognised to have a highly active calmodulin dependent component, rat cerebral cortex.3 The preparation and conditions of assay for rat cerebral cortex were conducted in exactly the same way as for human duodenal biopsy specimens. This tissue clearly showed the following characteristics: (a) the calmodulin content of the preparation was reduced by 25% by the EGTA washing procedure used, (b) a biophasic response to calcium (activation followed by inhibition) 5 0 with a maximum requirement for free [Ca2+] of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [tmol/l, (c) the addition of 10 ,ug/ml calmodulin to EGTA wash particulate preparate tions stimulated adenylate cyclase activity by 30-60% in the presence and absence of 5 mmol/l ree NaF (Table III) It may be that in our assay system, in which both brush border and basolateral membranes are present, the tightly bound brush border membrane calmodulin becomes available to influence the basolateral membrane adenylate cyclase. But if this were so, and we had been measuring a fully calmodulin stimulated adenylate cyclase system, we would have expected to be able to block the calmodulin effect with calmodulin antagonist (at concentrations specific to calmodulin) and this was not the case. The IC50 for trifluoperazine and IODO 8 were well in excess of those reported for other calmodulin dependent enzymes (6-50 and 3-10 ,tmol/l respectively).123536 Interestingly, the distribution of calmodulin in the membranes of rat enterocytes seems to be different from that of human enterocytes. Charpin et al37 reported that in rat duodenal basolateral membranes fractions calmodulin could be detected. Although further investigations are necessary to confirm our findings, these preliminary data indicate that adenylate cyclase in the human duodenal mucosa is calmodulin independent. This implies that increasing the specificity of calmodulin antagonists for use as antidiarrhoeal drugs, which operate through the adenylate cyclase system, would have little pharmacological benefit. It would be interesting to see if human jejunal and ileal tissue adenylate cyclase activity behaves in a similar way.
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